ImmunoPrecise Antibodies Ltd.
(TSX Venture Exchange : IPA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 5.53%219.760.0%$1925.11m
BIIBBiogen, Inc. -1.48%375.261.7%$1315.19m
SNSSSunesis Pharmaceuticals, Inc. -7.49%11.860.7%$829.06m
NVAXNovavax, Inc. 6.29%192.3879.8%$797.88m
AMGNAmgen, Inc. -0.27%239.601.3%$661.70m
BNTXBioNTech SE 3.62%234.270.0%$572.95m
VRTXVertex Pharmaceuticals, Inc. 0.23%188.131.9%$535.32m
GILDGilead Sciences, Inc. -0.46%67.041.0%$495.71m
REGNRegeneron Pharmaceuticals, Inc. -0.08%533.842.7%$388.10m
ILMNIllumina, Inc. 0.63%463.973.5%$351.58m
ALXNAlexion Pharmaceuticals, Inc. -0.58%179.612.0%$337.94m
OCGNOcugen, Inc. -5.74%6.980.0%$323.22m
TXG10X Genomics, Inc. 0.53%198.930.0%$178.29m
EXASEXACT Sciences Corp. 0.66%128.5018.1%$177.57m
TECHBio-Techne Corp. 0.13%440.764.5%$164.05m

Company Profile

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.